Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course

Cardiac Surgery With Cardiopulmonary Bypass Clinical Trial

— BLOCK  

Official title:

Use and Prescription of Beta-blockers Before Cardiac Surgery With Cardiopulmopnary Bypass: Multicenter Observational Analysis of Practices and Its Association With Postoperative Morbidity-mortality.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04769752
• Other study ID #: Guinot 2021
• Status: Completed
• Start date: June 2020
• Est. completion date: December 22, 2023

Study information

• Verified date: February 2023
• Source: Centre Hospitalier Universitaire Dijon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this study is to describe in a cohort of cardiac surgery patients the use of beta-blockers before surgery and their maintenance or withdraw according to international recommendations in order to compare patients who receive a beta-blocker with maintenance during the surgical period (international recommendation) to those for whom prescription and maintenance are not respected. Patients are treated according to standard practice and this protocol does not change patient management. No additional information or data is required by the study other than the data usually collected in the patient record (drug treatment, medical history, operating data, postoperative data, complications, length of stay). The objectives of this research are : - To evaluate the proportion of patients receiving beta-blocker treatment prior to cardiac surgery. - To evaluate the proportion of patients receiving beta-blocker treatment before cardiac surgery and complying with international recommendations for its maintenance/stop in perioperative cardiac surgery. - To evaluate the incidence of complications and length of hospital stay in patients receiving beta-blockers based on compliance or non-compliance with recommendations.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1789
• Est. completion date: December 22, 2023
• Est. primary completion date: December 22, 2023
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major patient = 18 years
• Patient operated cardiac surgery with cardiopulmonary bypass
• Patients who have given oral consent to participate after full information

Exclusion Criteria:

• Off pump cardiac surgery

Related Conditions & MeSH terms

• Cardiac Surgery With Cardiopulmonary Bypass

Intervention

Other:
• collection of the allocated treatment
collection of the allocated treatment
• collection of medical complications
collection of medical complications

Locations

Country	Name	City	State
France	Chu Dijon Bourogne	Dijon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients treated with beta-blocker in accordance with international guidelines	Number of patients treated with beta-blocker in accordance with international guidelines	7 days